These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 10950676)
21. FDA tells senators of doctors who fake data in clinical drug trials. Holden C Science; 1979 Oct; 206(4417):423-3. PubMed ID: 504984 [No Abstract] [Full Text] [Related]
22. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? No. Lawton V BMJ; 2009 Nov; 339():b4953. PubMed ID: 19946144 [No Abstract] [Full Text] [Related]
23. Reply to 'Truth in numbers'. Kim PS Nat Med; 2006 Mar; 12(3):269. PubMed ID: 16520764 [No Abstract] [Full Text] [Related]
24. Influence of drug company authorship and sponsorship on drug trial outcomes. Tungaraza T; Poole R Br J Psychiatry; 2007 Jul; 191():82-3. PubMed ID: 17602130 [TBL] [Abstract][Full Text] [Related]
25. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy? Ferris LE CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844 [No Abstract] [Full Text] [Related]
28. Is academic medicine for sale? Firlik AD; Lowry DW N Engl J Med; 2000 Aug; 343(7):509-10. PubMed ID: 10950674 [No Abstract] [Full Text] [Related]
29. Drug development history, "overview," and what are GCPs? Heilman RD Qual Assur; 1995 Mar; 4(1):75-9. PubMed ID: 8520867 [TBL] [Abstract][Full Text] [Related]
30. Commentary: Epidemiology and the pharmaceutical industry: an inside perspective. Haas J Int J Epidemiol; 2008 Feb; 37(1):53-5; discussion 65-8. PubMed ID: 18184672 [No Abstract] [Full Text] [Related]
31. Making clinical trials safer for human subjects. Baram M Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112 [No Abstract] [Full Text] [Related]
32. US proposes more stringent conflict-of-interest rules. Kondro W CMAJ; 2007 May; 176(11):1571-2. PubMed ID: 17515579 [No Abstract] [Full Text] [Related]
35. Advisors may urge NIH to seek out industry support for clinical trials. Appel A Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301 [No Abstract] [Full Text] [Related]
36. [Something for something--physicians, drug industry and general welfare]. Bro F; Olesen F Ugeskr Laeger; 2006 Nov; 168(46):3985. PubMed ID: 17125648 [No Abstract] [Full Text] [Related]
37. Bias in the design, interpretation, and publication of industry-sponsored clinical research. Hammerschmidt D Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022 [No Abstract] [Full Text] [Related]
38. The impact of escalating regulatory requirements on the conduct of clinical research. Gordon BG; Kessinger A; Mann SL; Prentice ED Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237 [TBL] [Abstract][Full Text] [Related]
39. Researchers left to guess at outcomes of most cancer clinical trials. Twombly R J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774 [No Abstract] [Full Text] [Related]